Raphael Pharmaceutical (RAPH) Long-Term Deferred Tax (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Long-Term Deferred Tax of $8.8 million for Q4 2025, up 26.81% sequentially from $7.0 million in Q4 2024, and up 26.81% YoY from $7.0 million in Q4 2024.
Raphael Pharmaceutical (RAPH) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Long-Term Deferred Tax for 6 years, with the latest figure at $8.8 million in Q4 2025.
- Quarterly Long-Term Deferred Tax rose 26.81% year-over-year to $8.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.8 million (up 26.81% YoY) and the FY2025 annual result came in at $8.8 million, up 26.81% from the prior year.
- Long-Term Deferred Tax advanced to $8.8 million in Q4 2025 per RAPH's latest filing, from $7.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $8.8 million in Q4 2025 and troughed at $3.2 million in Q4 2022.
- A 5-year average of $6.1 million and a median of $5.7 million in 2021 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax jumped 736.39% in 2021, then slumped 44.31% in 2022.
- Over 5 years, Long-Term Deferred Tax stood at $5.7 million in 2021, then plunged by 44.31% to $3.2 million in 2022, then surged by 79.41% to $5.7 million in 2023, then gained by 21.32% to $7.0 million in 2024, then gained by 26.81% to $8.8 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $8.8 million, $7.0 million, and $5.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.83 Mn |
| Dec 31, 2024 | 6.97 Mn |
| Dec 31, 2023 | 5.74 Mn |
| Dec 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | 5.75 Mn |
| Dec 31, 2020 | 687,000.00 |